- (84) 12345-6789
An important goal of CIAPM is to develop an inventory of public and private precision medicine assets in the state and to identify strategic areas for future development across California.
California’s strength in high-tech and life-science entrepreneurship makes it an ideal place to drive innovation and capacity in precision medicine. Equally important, California’s world-class public and private universities and research institutes represent an invaluable asset for data-driven medicine. Within the UC system alone are 10 campuses that encompass expansive scientific, clinical and computational expertise and 5 medical centers that collectively hold over 13 million electronic health records, representing one of the nation’s largest and most diverse patient populations. This rich resource is further augmented by other health care providers in California, with a socioeconomically diverse patient base. This confluence of high tech innovation with scientific and clinical capability places California in a unique position to accelerate precision medicine efforts toward improving medical outcomes for individuals from all walks of life.
The purpose of the California precision medicine asset inventory is to:
We anticipate that coordinating efforts will strengthen California’s precision medicine capabilities and attract additional funding for initiative activities.
The development of the California Precision Medicine Asset Inventory is currently in progress.
Examples of assets include:
Databases and infrastructure